WALTHAM, Mass.--(BUSINESS WIRE)--
NeuroMetrix, Inc. (NURO),
a health-care company that develops wearable medical technology and
point-of-care tests, reported that Shai N. Gozani M.D., Ph.D., President
and Chief Executive Officer, is scheduled to speak at the Rodman &
Renshaw 17th Annual Global Investment Conference on September
10, 2015 at 3:25 pm EDT. Dr. Gozani intends to provide an update on the
Company's business activities including the Quell™ Wearable Pain Relief
device.
A live audio webcast will be available on the investor relations section
of the NeuroMetrix corporate website at http://www.NeuroMetrix.com/
and will be archived after the event.
About NeuroMetrix
NeuroMetrix is an innovative health-care company that develops wearable
medical technology and point-of-care tests that help patients and
physicians better manage chronic pain, nerve diseases, and sleep
disorders. The company is located in Waltham, Massachusetts and was
founded as a spinoff from the Harvard-MIT Division of Health Sciences
and Technology in 1996. For more information, please visit www.NeuroMetrix.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150903006394/en/
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and
Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
News Provided by Acquire Media
